Weiss Multi-Strategy Advisers’s Intersect ENT, Inc XENT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$228K	–	737
2019 Q2	$228K	Buy	+10,000	New	+$270K	0.01%	462

Weiss Multi-Strategy Advisers's XENT Position: Q2 2022 in Review

Weiss Multi-Strategy Advisers sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 75,569 shares — an estimated $2.12M sold.

Weiss Multi-Strategy Advisers first reported a position in XENT in Q1 2018 and held it in 15 quarters. The position peaked at $2.12M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Weiss Multi-Strategy Advisers reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 75,569 Intersect ENT, Inc shares in Q2 2022, an estimated $2.12M.
Weiss Multi-Strategy Advisers first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Intersect ENT, Inc position peaked at $2.12M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.